Lifeward (LFWD) Proxy Filing summary

Executive summary

• The annual meeting is scheduled for August 1, 2025, with in-person attendance planned and remote options if needed.

• Shareholders will vote on eight key proposals, including director elections, executive compensation, incentive plans, and auditor reappointment.

• The Board recommends voting in favor of all proposals and emphasizes the importance of shareholder participation.

Voting matters and shareholder proposals

• Proposals include reelection of three directors, ratification of CEO compensation, approval of chairperson fees, adoption of a new incentive plan, ratification of equity compensation for a director, increase in authorized share capital, auditor reappointment, and a say-on-pay vote.

• Each proposal requires a simple majority, except CEO compensation, which also requires a special majority under Israeli law.

• Shareholders of record as of June 23, 2025, are eligible to vote; proxy and remote voting options are available.

• Shareholder proposals for the 2026 meeting must be submitted by February 27, 2026.

Board of directors and corporate governance

• The Board will consist of seven directors post-meeting, with a mix of experienced leaders from healthcare, finance, and technology.

• Committees include audit, compensation, and nominating/governance, all composed of independent directors per Nasdaq standards.

• The Board separates the roles of CEO and Chairperson and regularly reviews risk, governance, and compliance.

• Shareholder communications are centralized through the CFO, and a code of ethics applies to all officers, directors, and employees.